The UERM Memorial Hospital is the medical center for University of the East Ramon Magsaysay in Quezon City, Philippines. It opened in 1957 The hospital provides psychiatry, neurosurgery, ophthalmology, otorhinolaryngology, ambulatory medicine, rehabilitation medicine, and emergency medicine.

During the past decade, University of the East Ramon Magsaysay Memorial Medical Center conducted 4 clinical trials. In the 10-year time frame, 4 clinical trials started and 1 clinical trials were completed, i.e. on average, 25% percent of trials that started reached the finish line to date. In the past 5 years, 4 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "University of the East Ramon Magsaysay Memorial Medical Center" #1 sponsor was "Clover Biopharmaceuticals AUS Pty Ltd" with 1 trials, followed by "EuBiologics Co.,Ltd" with 1 trials sponsored, "Pfizer" with 1 trials sponsored, "Philippine Neurological Association" with 1 trials sponsored and "University of the Philippines" with 1 trials sponsored. Other sponsors include -5 different institutions and companies that sponsored additional 5 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "University of the East Ramon Magsaysay Memorial Medical Center" #1 collaborator was "Coalition for Epidemic Preparedness Innovations" with 1 trials as a collaborator and "International Vaccine Institute" with 1 trials as a collaborator. Other collaborators include -2 different institutions and companies that were collaborators in the rest 2 trials.

According to Clinical.Site data, the most researched conditions in "University of the East Ramon Magsaysay Memorial Medical Center" are "COVID-19" (1 trials), "Cerebral Venous Thrombosis" (1 trials), "Covid19" (1 trials), "Intracerebral Hemorrhage" (1 trials) and "Ischemic Stroke" (1 trials). Many other conditions were trialed in "University of the East Ramon Magsaysay Memorial Medical Center" in a lesser frequency.

Most popular intervention types in "University of the East Ramon Magsaysay Memorial Medical Center" are "Biological" (2 trials) and "Drug" (2 trials). Other intervention types were less common.

The name of intervention was led by "Acalabrutinib" (1 trials), "Axitinib (AG-013736)" (1 trials), "CpG 1018/Alum-adjuvanted SCB-2019 vaccine" (1 trials), "EuTCV (Vi-CRM Typhoid conjugate vaccine)" (1 trials) and "Hydroxychloroquine" (1 trials). Other intervention names were less common.

The vast majority of trials in "University of the East Ramon Magsaysay Memorial Medical Center" are 5 trials for "All" genders.

Currently, there are NaN active trials in "University of the East Ramon Magsaysay Memorial Medical Center". undefined are not yet recruiting, 1 are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 3 completed trials in University of the East Ramon Magsaysay Memorial Medical Center, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in University of the East Ramon Magsaysay Memorial Medical Center, 0 "Phase 1" clinical trials were conducted, 2 "Phase 2" clinical trials and 3 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 1 trials that are defined as “Not Applicable".